(S)-4-benzyl-3-phenethyl-1-(4-((S)-2-(prop-1-enyl)-4,5-dihydro-1H-imidazol-4-yl)butyl)imidazolidine-2-thione

ID: ALA4088559

PubChem CID: 137644174

Max Phase: Preclinical

Molecular Formula: C28H36N4S

Molecular Weight: 460.69

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C/C=C/C1=N[C@@H](CCCCN2C[C@H](Cc3ccccc3)N(CCc3ccccc3)C2=S)CN1

Standard InChI:  InChI=1S/C28H36N4S/c1-2-11-27-29-21-25(30-27)16-9-10-18-31-22-26(20-24-14-7-4-8-15-24)32(28(31)33)19-17-23-12-5-3-6-13-23/h2-8,11-15,25-26H,9-10,16-22H2,1H3,(H,29,30)/b11-2+/t25-,26-/m0/s1

Standard InChI Key:  HCOGFOCMFHOUHT-DAZCNLPFSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   19.2984   -8.5063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1147   -8.4696    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.3340   -7.6823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6501   -7.2304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0136   -7.7416    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.9028   -9.2211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0995   -7.3962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7300   -7.9161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4955   -7.6300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1260   -8.1499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8914   -7.8638    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.5715   -8.3154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2111   -7.8068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9250   -7.0412    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.1086   -7.0769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5995   -6.4377    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   25.9985   -8.0252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1356   -8.8311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5060   -9.3474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6425  -10.1523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4093  -10.4373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0401   -9.9111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9004   -9.1081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3760   -6.3598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1917   -6.4097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6023   -5.7031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4185   -5.7071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8290   -5.0014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4224   -4.2915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6010   -4.2918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1942   -4.9982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0857   -9.2360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6901   -9.9510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  1  6  1  0
  3  7  1  6
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 11  1  0
 15 16  2  0
 13 17  1  1
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 14 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
  6 32  2  0
 32 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4088559

    ---

Associated Targets(Human)

RORA Tchem Nuclear receptor ROR-alpha (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rorb Nuclear receptor ROR-beta (15 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rorc Nuclear receptor ROR-gamma (89407 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 460.69Molecular Weight (Monoisotopic): 460.2661AlogP: 4.86#Rotatable Bonds: 11
Polar Surface Area: 30.87Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.08CX LogP: 5.76CX LogD: 3.53
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.38Np Likeness Score: -0.04

References

1. Nefzi A, Marconi GD, Ortiz MA, Davis JC, Piedrafita FJ..  (2017)  Synthesis of dihydroimidazole tethered imidazolinethiones and their activity as novel antagonists of the nuclear retinoic acid receptor-related orphan receptors (RORs).,  27  (7): [PMID:28242276] [10.1016/j.bmcl.2017.02.014]

Source